Benefits of CIMZIA

CIMZIA is the only PEGylated anti-TNF. CIMZIA has an innovative design, allowing it to be injected just once every 4 weeks after initial dosing. CIMZIA is used to lessen the signs and symptoms of moderately to severely active Crohn's disease in adult patients who have not been helped enough by usual treatments.

CIMZIA may help give you control over your Crohn's disease symptoms

Some people taking CIMZIA had lessened symptoms, such as stomach pain and diarrhea. In clinical trials, these improvements were seen in some people regardless of how long they had Crohn's disease and regardless of what other Crohn's medications they may have taken in the past.

You may find that your experience with CIMZIA is similar to that of people in clinical trials.

CIMZIA provides rapid and long-lasting symptom relief

For some people in clinical trials, the benefits of CIMZIA were felt within a few short weeks. For many of them, this control of their Crohn's signs and symptoms lasted for up to 18 months when CIMZIA was taken continuously.

CIMZIA provides Crohn's treatment you can feel good about

CIMZIA has a low rate of injection site pain with less than 1% of patients experiencing stinging and burning. Allergic reactions in patients taking CIMZIA in clinical trials were rare.

Serious infections have happened in patients taking CIMZIA, including tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections.